Impact of renin-angiotensin system inhibitors on clinical outcomes and ventricular remodelling after transcatheter aortic valve implantation: rationale and design of the RASTAVI randomised multicentre study

INTRODUCTION: Transcatheter aortic valve implantation (TAVI) as a treatment in severe aortic stenosis (AS) is an excellent alternative to conventional surgical replacement. However, long-term outcomes are not benign. Renin-angiotensin system (RAS) blockade has shown benefit in terms of adverse remod...

Descripción completa

Detalles Bibliográficos
Autores principales: Amat-Santos, Ignacio J, Catalá, Pablo, Diez del Hoyo, Felipe, Fernandez-Diaz, Jose A, Alonso-Briales, Juan H, Del Trigo, María, Regueiro, Ander, Juan-Salvadores, Pablo, Serra, Vicenç, Gutierrez-Ibanes, Enrique, Muñoz-García, Antonio J, Nombela-Franco, Luis, Sabate, Manel, Jimenez-Diaz, Victor A, García del Blanco, Bruno, López, Javier, Varela-Falcón, Luis H, Sevilla, Teresa, Arnold, Roman, Revilla, Ana, San Roman, J Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829899/
https://www.ncbi.nlm.nih.gov/pubmed/29440218
http://dx.doi.org/10.1136/bmjopen-2017-020255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829899/
https://www.ncbi.nlm.nih.gov/pubmed/29440218
http://dx.doi.org/10.1136/bmjopen-2017-020255

Ejemplares similares